Agile Therapeutics
AGRX
#10289
Rank
S$13.3 M
Marketcap
S$1.93
Share price
0.00%
Change (1 day)
302.30%
Change (1 year)

Earnings for Agile Therapeutics (AGRX)

Earnings in 2024 (TTM): -S$20.23 Million

According to Agile Therapeutics 's latest financial reports the company's current earnings are S$21.56 Million. In 2023 the company made an earning of -S$16.66 Million a decrease over its 2022 earnings that were of -S$6.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agile Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$20.23 Million21.46%
2023 -S$16.66 Million172.57%
2022 -S$6.12 Million-93.26%
2021 -S$90.61 Million45.62%
2020 -S$62.23 Million161.98%
2019 -S$23.76 Million-2.78%
2018 -S$24.44 Million-27.47%
2017 -S$33.69 Million-10.16%
2016 -S$37.49 Million-14.2%
2015 -S$43.7 Million88.45%
2014 -S$23.19 Million41.72%
2013 -S$16.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.35 B-215,699.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.12 B-78,976.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.47 B-153,766.98%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
S$0.01 M-100.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
S$84.09 M-538.45%๐Ÿ‡บ๐Ÿ‡ธ USA